Hereditary Testing Market Size

The global hereditary testing market size was valued at USD 7.6 billion in 2024 and is estimated to grow at 7.7% CAGR from 2025 to 2034. Hereditary testing, also known as genetic testing, involves analyzing an individual's DNA to identify changes or mutations in genes, chromosomes, or proteins that are inherited from parents.

These tests are used to determine the likelihood of developing specific genetic disorders, confirm a suspected genetic condition, or understand the risk of passing a genetic disorder to offspring. The market is being propelled by a confluence of factors. The rising prevalence of genetic disorders and the growing awareness of their implications have heightened the demand for hereditary testing. For instance, according to the World Health Organization, genetic disorders and congenital abnormalities occur in approximately 2-5% of all live births. As individuals become more informed about their genetic predispositions, the need for proactive health measures has surged.

Additionally, advancements in genomic technologies have made testing more accessible and affordable, further fueling market growth. The integration of hereditary testing into routine healthcare, coupled with supportive government initiatives, underscores its significance in modern medicine. Expanding applications of hereditary testing, from prenatal screening to cancer risk assessment, have broadened its appeal. The increasing emphasis on personalized medicine, where treatments are tailored based on genetic profiles, has also bolstered the market. Furthermore, the rise of direct-to-consumer genetic testing has democratized access, allowing individuals to take charge of their health decisions.

As research continues to unveil the complexities of genetics, the market is poised for sustained growth, driven by both technological advancements and a deeper understanding of genetic implications.